GSK, U.K. researchers to search for drug to fight vCJD

04/13/2005 | Reuters

GlaxoSmithKline plans to work with Britain's Medical Research Council to search for a drug that can be used against the human version of BSE, vCJD. Researchers will screen drug-like molecules in GSK's vast library of compounds in hopes of finding a compound that can enter the brain and bind to the normal prion, preventing it from transforming into an infectious agent.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Accreditation
Meridian Health Plan
Detroit, MI
Stop Loss Sales Executive, (Southern Region)
Indigo Insurance Services
Multiple Locations, SL_Multiple Locations
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC